Glipizide
- Product NDC
- 59762-0541
- 11-digit product format
- 597620541
- Labeler code
- 59762
- Product ID
- 59762-0541_cf7479ea-f3c5-4b69-8cb0-264436ec14f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Greenstone LLC
- Application
- NDA020329
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2013-05-29
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59762-0541-1 | 59762054101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0541-1) | 2013-05-29 | 0000-00-00 | No | No | Current |
| 59762-0541-2 | 59762054102 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0541-2) | 2013-05-29 | 0000-00-00 | No | No | Current |